Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

ChemChina seeks EU okay for Syngenta deal, decision due October 28

Published 09/26/2016, 06:18 AM
Updated 09/26/2016, 06:20 AM
© Reuters. People use an escalator outside the headquarters of ChemChina (China National Chemical Corporation) in Beijing, China

BRUSSELS (Reuters) - China National Chemical Corp (ChemChina) [CNNCC.UL] has sought antitrust approval for its $43 billion bid for Swiss pesticides and seeds group Syngenta (S:SYNN) from the European Union and a decision is expected by Oct. 28.

State-owned ChemChina filed its request on Sept. 23, the European Commission's website showed on Monday.

The EU competition enforcer can either clear the deal, with or without concessions, or it can open a full investigation if it has serious concerns that ChemChina's takeover of the world's largest pesticides maker could harm customers and rivals.

ChemChina cleared one of the biggest hurdles last month when a U.S. national security panel approved what would be the largest foreign acquisition by a Chinese company.

The deal is one of several in the agrochemicals sector, including the planned $130 billion merger of Dow Chemical (N:DOW) and DuPont (N:DD), Bayer's (DE:BAYGn) $66 billion bid for Monsanto (N:MON) and Potash Corp of Saskatchewan's (TO:POT) proposed merger with Agrium (TO:AGU).

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.